跳至主要内容
临床试验/DRKS00022966
DRKS00022966已完成不适用

kidney.care 2.0

Medizinische Universität Graz0 个研究点目标入组 749 人开始时间: 2020年12月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
749

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40 Years 至 65 Years(—)
性别
All

入选标准

  • men and women of all ethnical groups aged between 40 and 65 years
  • - treated by a general practitioner with a § 2 health insurance contract
  • - written consent to participate in the study
  • Presence of at least one of the following risk factors:
  • - arterial hypertension (documented diagnosis of hypertension for at least 3 months, defined as systolic blood pressure >140 and diastolic blood pressure >90 mmHg)
  • - diabetes mellitus (defined as Typ 1 and Typ 2)
  • - adipositas (defined as body mass index > 30 -g/m2)
  • - end stage renal disease in the familiy (family is defined as children, parents and siblings)
  • - history of cardiovascular diseases (stroke, transient ischemic attack (TIA), coronary heart disease, peripheral arterial disease)

排除标准

  • - prior recorded diagnosis of CKD (defined as a documentation of chronic kidney disease)
  • - prior participation in kidney.care” (recorded eGFR/ACR diagnosis according to kidney.care” in the outpatient setting)
  • - kidney transplant recipients
  • - dialysis patients
  • - participants with an eGFR < 15 ml/min/1.73 m2
  • - participants with acute serious illness
  • - carcinoma patients
  • - NYHA III and IV
  • - expected life expectancy < 6 months
  • - Unable or unwilling to give informed consent (If a person cannot communicate with staff, s/he is unable to provide informed consent.)

研究者

相似试验

kidney.care 2.0 | 临床试验